The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
These dynamics can cause headaches for even the most seasoned professionals, which is why we started StockStory - to help you separate the good companies from the bad. Keeping that in mind, here are three stocks under $50 to swipe left on and some alternatives you should look into instead.
BrightView (BV)
Share Price: $12.06
An official field consultant for Major League Baseball, BrightView (NYSE: BV) offers landscaping design, development, and maintenance.
Why Should You Sell BV?
- Products and services are facing significant end-market challenges during this cycle as sales have declined by 1.4% annually over the last two years
- Falling earnings per share over the last five years has some investors worried as stock prices ultimately follow EPS over the long term
- Below-average returns on capital indicate management struggled to find compelling investment opportunities
BrightView’s stock price of $12.06 implies a valuation ratio of 17.3x forward P/E. Check out our free in-depth research report to learn more about why BV doesn’t pass our bar.
Inspire Medical Systems (INSP)
Share Price: $40.46
Offering an alternative for the millions who struggle with traditional CPAP machines, Inspire Medical Systems (NYSE: INSP) develops and sells an implantable neurostimulation device that treats obstructive sleep apnea by stimulating nerves to keep airways open during sleep.
Why Does INSP Worry Us?
- Subscale operations are evident in its revenue base of $915.2 million, meaning it has fewer distribution channels than its larger rivals
- Estimated sales decline of 8.3% for the next 12 months implies a challenging demand environment
At $40.46 per share, Inspire Medical Systems trades at 40.3x forward P/E. If you’re considering INSP for your portfolio, see our FREE research report to learn more.
Home Bancshares (HOMB)
Share Price: $26.16
Founded in Conway, Arkansas in 1998 and growing through strategic acquisitions across the Southeast, Home Bancshares (NYSE: HOMB) operates as the bank holding company for Centennial Bank, providing commercial and retail banking services to businesses and individuals across multiple states.
Why Is HOMB Not Exciting?
- Sales trends were unexciting over the last two years as its 5.6% annual growth was below the typical banking company
- 8.8% annual net interest income growth over the last five years was slower than its banking peers
- Annual earnings per share growth of 6.1% underperformed its revenue over the last five years, showing its incremental sales were less profitable
Home Bancshares is trading at $26.16 per share, or 1.2x forward P/B. Dive into our free research report to see why there are better opportunities than HOMB.
High-Quality Stocks for All Market Conditions
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
